224 related articles for article (PubMed ID: 27219328)
21. Downregulation of CPT1A exerts a protective effect in dextran sulfate sodium-induced ulcerative colitis partially by inhibiting PPARα signaling pathway.
Chen W; Zou J; Shi X; Huang H
Drug Dev Res; 2022 Sep; 83(6):1408-1418. PubMed ID: 35749635
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-γ interrupts angiogenic signal transduction by transrepression of platelet-derived growth factor-β receptor in hepatic stellate cells.
Zhang F; Kong D; Chen L; Zhang X; Lian N; Zhu X; Lu Y; Zheng S
J Cell Sci; 2014 Jan; 127(Pt 2):305-14. PubMed ID: 24259663
[TBL] [Abstract][Full Text] [Related]
23. rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway.
Wang L; Xie H; Xu L; Liao Q; Wan S; Yu Z; Lin D; Zhang B; Lv Z; Wu Z; Sun X
Theranostics; 2017; 7(14):3446-3460. PubMed ID: 28912887
[No Abstract] [Full Text] [Related]
24. Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence.
Colizzi M; Bortoletto R; Costa R; Zoccante L
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33919499
[TBL] [Abstract][Full Text] [Related]
25. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
[TBL] [Abstract][Full Text] [Related]
26. The role of PI3K/Akt/mTOR signaling in dose-dependent biphasic effects of glycine on vascular development.
Tsuji-Tamura K; Sato M; Fujita M; Tamura M
Biochem Biophys Res Commun; 2020 Aug; 529(3):596-602. PubMed ID: 32736679
[TBL] [Abstract][Full Text] [Related]
27. Pharmacoproteomics reveals the mechanism of Chinese dragon's blood in regulating the RSK/TSC2/mTOR/ribosome pathway in alleviation of DSS-induced acute ulcerative colitis.
Lin Y; Xiong W; Xiao S; Li F; Lu Z; Yan J; Fang X; Cui X; Wen Y; Liang J; Yu K
J Ethnopharmacol; 2020 Dec; 263():113221. PubMed ID: 32783984
[TBL] [Abstract][Full Text] [Related]
28. Lonicera rupicola Hook.f.et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K/AKT pathway.
Li C; Wang L; Zhao J; Wei Y; Zhai S; Tan M; Guan K; Huang Z; Chen C
Phytomedicine; 2022 Sep; 104():154284. PubMed ID: 35777121
[TBL] [Abstract][Full Text] [Related]
29. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.
Paterniti I; Impellizzeri D; Crupi R; Morabito R; Campolo M; Esposito E; Cuzzocrea S
J Neuroinflammation; 2013 Feb; 10():20. PubMed ID: 23374874
[TBL] [Abstract][Full Text] [Related]
30. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
Couch DG; Cook H; Ortori C; Barrett D; Lund JN; O'Sullivan SE
Inflamm Bowel Dis; 2019 May; 25(6):1006-1018. PubMed ID: 31054246
[TBL] [Abstract][Full Text] [Related]
31. Improved colonic inflammation by nervonic acid via inhibition of NF-κB signaling pathway of DSS-induced colitis mice.
Yuan SN; Wang MX; Han JL; Feng CY; Wang M; Wang M; Sun JY; Li NY; Simal-Gandara J; Liu C
Phytomedicine; 2023 Apr; 112():154702. PubMed ID: 36764096
[TBL] [Abstract][Full Text] [Related]
32. The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele.
Antonuccio P; Marini HR; Micali A; Romeo C; Granese R; Retto A; Martino A; Benvenga S; Cuzzocrea S; Impellizzeri D; Di Paola R; Fusco R; Cervellione RM; Minutoli L
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33668991
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen/AKT/Microfilament Axis Promotes Colitis by Enhancing Vascular Permeability.
Zhang C; Chen H; He Q; Luo Y; He A; Tao A; Yan J
Cell Mol Gastroenterol Hepatol; 2021; 11(3):683-696. PubMed ID: 33075564
[TBL] [Abstract][Full Text] [Related]
34. Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways.
Lee H; Son YS; Lee MO; Ryu JW; Park K; Kwon O; Jung KB; Kim K; Ryu TY; Baek A; Kim J; Jung CR; Ryu CM; Park YJ; Han TS; Kim DS; Cho HS; Son MY
Theranostics; 2020; 10(11):5048-5063. PubMed ID: 32308767
[TBL] [Abstract][Full Text] [Related]
35. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor receptor-2 inhibition in experimental murine colitis.
Knod L; Donovan EC; Chernoguz A; Crawford KM; Dusing MR; Frischer JS
J Surg Res; 2013 Sep; 184(1):101-7. PubMed ID: 23688787
[TBL] [Abstract][Full Text] [Related]
37. Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
Scuderi C; Stecca C; Valenza M; Ratano P; Bronzuoli MR; Bartoli S; Steardo L; Pompili E; Fumagalli L; Campolongo P; Steardo L
Cell Death Dis; 2014 Sep; 5(9):e1419. PubMed ID: 25210802
[TBL] [Abstract][Full Text] [Related]
38. A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
Da Silva S; Keita ÅV; Mohlin S; Påhlman S; Theodorou V; Påhlman I; Mattson JP; Söderholm JD
Inflamm Bowel Dis; 2018 Mar; 24(4):792-805. PubMed ID: 29529198
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
40. β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways.
Almarzooqi S; Venkataraman B; Raj V; Alkuwaiti SAA; Das KM; Collin PD; Adrian TE; Subramanya SB
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
